Form 8-K - Current report:
SEC Accession No. 0001654954-21-012024
Filing Date
2021-11-12
Accepted
2021-11-12 08:06:01
Documents
18
Period of Report
2021-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mnpr_8k.htm   iXBRL 8-K 24004
2 PRESS RELEASE mnpr_ex991.htm EX-99.1 17800
3 IMAGE mnpr_ex991img1.jpg GRAPHIC 887
4 IMAGE mnpr_ex991img2.jpg GRAPHIC 940
5 IMAGE mnpr_ex991img3.jpg GRAPHIC 5013
  Complete submission text file 0001654954-21-012024.txt   182882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20211112.xsd EX-101.SCH 5595
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20211112_cal.xml EX-101.CAL 890
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20211112_def.xml EX-101.DEF 2097
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20211112_lab.xml EX-101.LAB 15355
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20211112_pre.xml EX-101.PRE 9782
11 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_8k_htm.xml XML 3709
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 211399755
SIC: 2834 Pharmaceutical Preparations